Position in TYRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$284,921,183
-$11,813,734 QoQ
Shares Held
8,920,513
+15.1% QoQ
Ownership
14.9%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2
of 169 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. TYRA ranks #55 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in TYRA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $284,921,183 | 8,920,513 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $296,734,917 | 7,747,648 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $330,280 | 12,563 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $175,279 | 12,529 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $116,771 | 12,202 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,876,475 | 1,707,148 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $43,200,782 | 3,107,970 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $79,295,703 | 3,372,850 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $53,513,139 | 3,346,663 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $65,226,211 | 3,977,208 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $38,346,439 | 2,768,696 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $53,686,847 | 3,898,827 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $70,110,277 | 4,116,869 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $50,588,150 | 3,147,987 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $29,481,334 | 3,879,123 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $35,391,184 | 4,026,301 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $28,371,842 | 3,968,090 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $43,763,908 | 4,090,085 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $48,806,451 | 3,468,831 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $33,573,311 | 1,908,659 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||